Editas Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Editas Medicine (Nasdaq: EDIT), a clinical-stage gene editing company, has announced its participation in four upcoming investor conferences in September and October 2024. The company's management will engage in fireside chat discussions about Editas and its programs, including reni-cel.

The conferences include:

• Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
• 2024 Wells Fargo Healthcare Conference on September 5 in Boston
• 2024 Cantor Global Healthcare Conference on September 17 in New York
• Chardan 8th Annual Genetic Medicines Conference on October 1 in New York

Live webcasts of Editas Medicine's presentations will be available on the company's website, with archived replays accessible for approximately 30 days after each event.

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor conferences to discuss the Company and its programs, including reni-cel:

• Morgan Stanley 22^nd Annual Global Healthcare Conference
  Format: Fireside Chat
  Date: Wednesday, September 4
  Time: 4:05 p.m. ET
  Location: New York, NY

• 2024 Wells Fargo Healthcare Conference
  Format: Fireside Chat
  Date: Thursday, September 5
  Time: 4:30 p.m. ET
  Location: Boston, MA

• 2024 Cantor Global Healthcare Conference
  Format: Fireside Chat
  Date: Tuesday, September 17
  Time: 1:20 p.m. ET
  Location: New York, NY

• Chardan 8^th Annual Genetic Medicines Conference
  Format: Fireside Chat
  Date: Tuesday, October 1
  Time: 4:00 p.m. ET
  Location: New York, NY

To access the live webcasts of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.

About Editas Medicine
As a clinical-stage gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

FAQ

What investor conferences will Editas Medicine (EDIT) attend in September and October 2024?

Editas Medicine will participate in four investor conferences: Morgan Stanley Global Healthcare Conference (Sept. 4), Wells Fargo Healthcare Conference (Sept. 5), Cantor Global Healthcare Conference (Sept. 17), and Chardan Genetic Medicines Conference (Oct. 1).

Where can I watch Editas Medicine's (EDIT) presentations from the 2024 investor conferences?

Live webcasts of Editas Medicine's presentations will be available in the 'Investors' section of the company's website at www.editasmedicine.com. Archived replays will be accessible for about 30 days after each event.

What format will Editas Medicine's (EDIT) presentations take at the 2024 investor conferences?

Editas Medicine's presentations at all four investor conferences will be in a fireside chat format, allowing for discussion about the company and its programs, including reni-cel.

When and where will Editas Medicine (EDIT) present at the Morgan Stanley Global Healthcare Conference in 2024?

Editas Medicine will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 4:05 p.m. ET in New York, NY.

What is the date and time of Editas Medicine's (EDIT) presentation at the 2024 Chardan Genetic Medicines Conference?

Editas Medicine will present at the Chardan 8th Annual Genetic Medicines Conference on Tuesday, October 1, 2024, at 4:00 p.m. ET in New York, NY.